To Our Users:
Gap-App, offered at no cost, is tailored specifically for cancer patients with pancreatic ductal adenocarcinoma (PDAC) and their care providers. As the first online tool aiming to bridge the gap between complex genomic data and clinical application, it facilitates more precise and individualized cancer care. Gap-App boasts an accuracy of 92.62% for males and 91.96% for females. Detailed information on how the models are trained can be found in the publication here.
To enhance your privacy and convenience, Gap-App does not require users to log in. The app operates with just two inputs: your sex and gene expression data of the primary tumor from an RNAseq test targeting the whole transcriptome. Based on this, Gap-App predicts your 3-year survival outcome from the date the gene expression data is collected. Your anonymity is guaranteed as we do not collect or store any personal info that could identify you, keeping your data safe and anonymous.
Sex
Please upload your CSV or Excel file that contains gene expression values in FPKM format